Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer

This is a study that aims to demonstrate the non-inferiority of minimally invasive surgery versus open surgery, as an approach for patients with advanced ovarian cancer who received neoadjuvant chemotherapy, giving them the benefits of laparoscopic surgery. This way they can continue with their complementary treatment.

Trial Details

NCT ID
NCT06883409
Phase
NA
Sponsor
Instituto Nacional de Cancerologia de Mexico
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Interval Cytoreduction Surgery
Locations (sample)
  • México, Tlalpan, Mexico|31.00435,-108.15213

Key Eligibility Criteria

  • Diagnosis of epithelial ovarian cancer (all subtypes of epithelial ovarian cancer) in stage III-IV
  • Partial and complete response to treatment with QTNA after 3-4 cycles, evaluated by PET-CT imaging study, patients that the functional unit decides…
  • Ca 125 which will have to be less than 200
  • ECOG 0 to 2 without medical contraindication to perform surgery (≤ ASA 2 or ≤ Goldman 2).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →